Please login to the form below

Not currently logged in
Email:
Password:

myeloma

This page shows the latest myeloma news and features for those working in and with pharma, biotech and healthcare.

BMS’ Q2 results beat expectations with strong performance across core therapy areas

BMS’ Q2 results beat expectations with strong performance across core therapy areas

Bringing in the most sales in the quarter was multiple myeloma drug Revlimid, which was up by 11% from the previous quarter, bringing in $3.2bn.

Latest news

More from news
Approximately 88 fully matching, plus 259 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...